Overview

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The ability of glucagon-like peptide 1 to enhance beta-cell responsiveness to I.v. glucose is impaired in patients with type 2 diabetes mellitus compared with healthy individuals. We investigated whether 4 weeks of near-normalisation og blood glucose improves the potentiation of glucose-stimulated insulin secretion by GLP-1
Phase:
N/A
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Glucagon
Glucagon-Like Peptide 1